Peter Gilling FRACS

Professional Memberships:

Royal Australasian College of Surgeons (RACS) – Fellow.
New Zealand Medical Association (NZMA) – Full Member.
Urological Society of Australia and New Zealand (USANZ) – Full Member.
Société Internationale D’Urologic (SIU) – Full Member.
American Urological Association (AUA) – Corresponding Member.
European Association of Urology (EAU) – Corresponding Member.
British Association of Urological Surgeons (BAUS) – Corresponding Member.
International Continence Society (ICS) – Full Member.
Endourological Society – Associate Member.
Society for Minimally Invasive Therapy (SMIT) – Full Member.

Qualifications:

MB ChB University of Otago, 10 December 1982.
Fellow of the Royal Australasian College of Surgeons (FRACS), Urology,September 1991.
Visa Qualifying Examination (VQE), ECFMG No. 375-684-8 (1983).

Postgraduate Awards and Fellowships:

1982: Sir Thaddeus McNaughton Prize for Surgery (Undergraduate).
1985, 1986, 1989: Runner-up Davis & Geck Award for Surgical Trainees.
1987: Waikato Junior Postgraduate Medical Award.
1988-89: Leslie Averill Research Fellowship.
1989: Wolf Urology Prize.
1990: Wolf Urology Prize.
1991-92: Fellowship in Clinical Urology U.T. Southwestern Medical Center, Dallas Texas.
1999 – present: Honorary Senior Lectureship, University College London, UK.
2001: Alban Gee Prize.

Educational Appointments:

1998 – 2001: Training Education and Accreditation (TEA) Committee (NZ).
2002 – present: Examiner (Urology), Court of Examiners, Royal Australasian College of Surgeons.
2005 – present: Chairman, Lower Urinary Tract Special Advisory Group, USANZ
2005 – present: Member, Continuing Professional Development(CPD) Committee, USANZ
2006 – Present: Member, Research Sub-Committee, BOP Clinical School.

Past Postgraduate Clinical Appointments:

Post-Graduate Training

1983-84: 1st and 2nd year House Surgeon, Canterbury Hospital Board, Christchurch, NewZealand.
1985-86: General Surgical Registrar, 1st and 2nd year, Canterbury Hospital Board, attachments to General Surgery 1 year, Neurosurgery 6 months, full-time Urology 6months, Christchurch, New Zealand.
1987: Year I: Advanced training in Urology, Waikato Hospital, Hamilton, NewZealand.
1988: Year II: Advanced training in Urology, General Surgery 12 months, Paediatric General Surgery 6 months, General Surgery 6 months, Christchurch, New Zealand.
1989: Year III: Advanced training in Urology, Leslie Averill Research Fellow, full-time research - Urodynamics and Bladder Muscle Contractility: Professor Ted Arnold, Christchurch, New Zealand.
1990: Year IV: Advanced training in Urology, full time Clinical Urology, Christchurch Hospital, Christchurch, New Zealand.

Post-Fellowship appointments

1991-92: Clinical Urology Fellowship, University of Texas Southwestern Medical Centre at Dallas, Texas, USA, (Sponsor: Professor Paul C Peters).

Currently:

1992 – present: Consultant Urologist, Tauranga Hospital and Grace Hospital, Tauranga, New Zealand. Consultant Urologist, Promed Urology Limited, Tauranga, New Zealand.
1999 – present: Honorary Senior Lecturer, Institute of Urology, University College, London, UK.
2000 – present: Head of Department, Urology, Tauranga Hospital, Tauranga, New Zealand.
2005 – present: Chairman, Venturo Limited, Bay of Plenty Health District, Tauranga, New Zealand.

Advisory Panels/Committees:

International - Industry:

Lumenis Advisory Board.
Uromedica Advisory Board.. .

Australasia - Industry:

Novartis Urology Advisory Board.

Other:

Faculty of 1000 Medicine (BPH section).
Bay Health Foundation - Advisory Trustee

Data Safety and Monitoring Committees:

2006-present: Continence Control Systems International Pty Ltd – Utrol^Tm Neurostimulation System.

Journal Article Reviewer

Journal of Urology
European Urology
Urology
British Journal of Urology
Journal of Endourology
Various others

Visiting Professorships:

1997: Royal Prince Alfred Hospital (Inaugural Gamble Visiting Professor), Sydney, Australia
1997: McGill University, Montreal, Canada.
2002: Dartmouth-Hitchcock Medical Centre, Lebanon NH, USA.
2002: South Australian Section (USANZ), Melbourne, Australia.
2003: University of Alberta, Edmonton, Canada.
2006: Western Australian Section (USANZ), Perth, Australia
2008: South Australian Section (USANZ), Adelaide, Australia

Invited Faculty - International Meetings:

1994 Royal Australasian College of Surgeons Annual Scientific Meeting,
1994 RACS meeting 1994.
Société Internationale D'Urologie Congress Meeting, Sydney, Australia, September 1994
12^th World Congress on Endourology and SWL, St Louis, Missouri, December 1994,

International Faculty.

14^th World Congress of Endourology and SWL, Melbourne, Australia, November 1996, International Faculty/Moderator.
15^th World Congress on Endourology and SWL 13^th Basic Research Symposium, Edinburgh, ScotlandAugust 1997, International Faculty/Moderator.
EAU Congress 1998, Invited Faculty
16^th World Congress of Endourology and SWL, New York, September 1998.
17^th World Congress of Endourology and SWL, New York, September 1999.
Urological Society of Australasia 2000 Annual Scientific Meeting, Sydney, Australia, March 2000
18^th World Congress of Endourology and SWL, Sao Paulo, Brazil, September 2000.
19^th World Congress of Endourology and SWL, Bangkok, Thailand, November 2001.
20^th World Congress of Endourology and SWL, Genoa, Italy, September 2002.
21^st World Congress of Endourology and SWL, Quebec, Canada, September 2003.
EAU Congress 2004, Vienna, February 2004.
69^th Annual Spanish Congress, Oviedo, Spain, June 2004.
22^nd World Congress of Endourology and SWL, Mumbai, India, November 2004
23^rd World Congress of Endourology and SWL, Amsterdam, Netherlands 2005
American Urological Association (AUA), Atlanta, Georgia May 2006
24^th World Congress of Endourology, Cleveland, Ohio August 2006
Société Internationale D'Urologie Congress, South Africa, November 2006
USANZ meeting, Adelaide, Febuary, 2007.
25^thWorld Congress of Endourology and SWL, Cancun. October 2007
USANZ Meeting, Hong Kong, Febuary 2008
EAU Congress Milan, March 2008
AUA Meeting Orlando, May 2008
Asian Congress of Urology, Dehli, October 2008

Faculty – Urology Symposia and Instructional Courses:

Urology Symposia/Visiting Faculty

Prince of Wales Hospital, Hong Kong, 1995.
Beijing Medical University Hospital, Beijing, 1995.
Kurume University Hospital, Kurume, Japan, 1995.
St Josephs Hospital, Toronto, Canada, 1996.
Derby City General Hospital, Great Britain, 1996.
International Hospital, Istanbul, Turkey, 1996.
Rotorua, New Zealand, 1996.
St Vincent’s Hospital, Melbourne, Australia, 1997.
Hôpital Erasme, Brussels, 1997.
Western General Infirmary Edinburgh, 1997.
Klinik Grosshadern, Munich, 1997.
AVK (Auguste-Viktoria-Krankenhaus), Berlin, 1997.
Jewish General Hospital, Montreal, Canada, 1997.
Royal Prince Alfred Hospital, Sydney, Australia, 1997.
AVK (Auguste-Viktoria-Krankenhaus) Berlin, 1998.
Fairmont Hotel, San Jose, 1998.
Fairmont Hotel, Dallas Texas, 1999.
Institute of Urology – Middlesex Hospital, London 1998, 1999, 2001.
St Vincents/Westmead Hospitals, Sydney, Australia, 1999.
Laser Masterclass, USA Meeting, Sydney, Australia, 2000.
Mariott Marquess, Atlanta, USA, 2000.
Gran Melia Hotel, Sao Paulo, Brazil, 2000.
Conrad International Hotel, Singapore, 2000.
Singapore General Hospital, Singapore, 2000.
Grand Californian Hotel, Anaheim, USA, 2001.
RACS Meeting, Palmerston North, New Zealand, 2001.
29^th Endourological Symposium, Munich, Germany, 2001.
Sofitel Hotel Bangkok Convention Centre, Bangkok, Thailand, 2001.
Birmingham Metropole, National Exhibition Centre, Birmingham, UK, 2002.
Portofino Hotel, Orlando, USA, May, 2002.
Scottish Exhibition and Conference Centre (SECC), Glasgow, Scotland, 2002.
SIU Stockholm, September 2002.
Gavazzeni Clinic, Bergamo, Italy, October 2002.
St Vincents Hospital, Melbourne, Australia, October 2002.
Carlos Haya Hospital, Malaga, Spain, March 2003.
Hospital Central de Asturia, Oviedo, March 2003.
San Rafael Hospital, Milan, March 2004.
AVK Hospital, Vienna Austria, March 2004.
AVK Hospital Berlin, June 2004.
St James Hospital, Leeds, UK, June, 2004.
The London Clinic, London, UK, June 2004.
Carlos Haya Hospital, Malaga, Spain, June 2004.
Institute of Medical Education Research, Chandigarh, India April 2005
Carlos Haya Hospital Endourology Symposium, Malaga, Spain, June 2005
Mainz, Germany 2005
13^th Endourological Symposium, Munich, Germany October 2005
Carlos Haya Hospital Endourology Symposium, Malaga, Spain, May 2006
AUA Atlanta – Holmium Laser Prostatectomy IC – May 2006
United Hospital – St Paul MN. May 2006
Nepean Hospital, Sydney, July 2006
Caritas Hospital, Hong Kong, October, 2006
Freemantle Hospital, Perth, November, 2006
Adan Hospital, Kuwait December, 2006
Addenbrookes Hospital, Cambridge, UK, March, 2007
Addenbrookes Hospital, Cambridge, UK April, 2008

Laparoscopy Workshops - Faculty

Laparoscopy for Urologists – Tauranga, New Zealand, 2-3 April 1993.
aparoscopy for Urologists – Tauranga, New Zealand, 25-26 June 1993.
Laparoscopic Extraperitoneal Inguinal Herniorrhaphy, Tauranga, New Zealand, 27 November 1993.
Laparoscopic Extraperitoneal Bladder Neck Suspension, Tauranga, New Zealand, 26 March1994.
Advanced Laparoscopy for Urologists - Christchurch, New Zealand. 14-16 July 1994.
Advanced Laparoscopy – Coolum, Queensland, Australia, 2001.

Research:

Holmium Laser and Device Trials – Single Site (Principal Investigator):

January 1994 – December 1995: Holmium Laser Resection (HoLRP) vs Visual Laser Ablation (VLAP) of the Prostate.
January 1996 – December 2003: FDA Study. Coherent, #960223, Holmium: YAG Laser Resection of the Prostate (HoLRP) versus Transurethral Electrocautery Resection of the Prostate (TURP): A Prospective Randomised Urodynamics-Based Clinical Trial.
June 1998 – December 2003: Holmium Laser Enucleation (HoLEP) vs (TURP) for Large Prostates.
June 1998 – December 2003: Holmium Laser Bladder Neck Incision (HoLBNI) vs HoLEP for small prostates.
May 2000 – December 2001: Neotonus, Urinary Incontinence in Women, Neocontrol (ExMI) Magnetic Innervation of Pelvic Floor Muscles vs Sham, RCT, single site, principal investigator.
November 2001 – June 2002: American Medical Systems, Bioflow Degradable Urethral Stent Post-brachytherapy.
January 2002 – December 2004: Gyrus. A randomised sudy comparing HoLEP and Plasmakinetic Enucleation (PkEP).
November 2001 – June 2003: American Medical Systems, Bioflow Degradable Urethral Stent for Bulbourethral Strictures.
August 2004 – ongoing: Gyrus A prospective comparative clinical study of Plasmakinetic Electrocautery Resection of the Prostate (PkERP)for the treatment of Benign Prostatic Hyperplasia (BHP) for prostates 40-200gms (TRUS volume).
January 2008 – ongoing: StarMedTec GmbH, A Prospective Clinical Study of Low Power (50W) Holmium Laser Enucleation (HoLEP) for the Treatment of Benign Prostatic Hyperplasia (BPH) for prostates ≤100gms (TRUS Volume). Principal Investigator.

Multinational Device Studies:

April 2001 – March 2006: American Medical Systems, Global Transurethral Ethanol Ablation of the Prostate (TEAP) for Benign Prostatic Hyperplasia and Long Term Follow-up (GETs Study). Joint Principal Investigator.
October 2001 – ongoing: Uromedica, Clinical Investigation of an Adjustable Continence Therapy (ProACT) Implant, for the Treatment of Male Post Prostatectomy Urinary Incontinence. Joint Principal Investigator.
October 2003 – November 2005: Cosman Company, Pilot Study of a transurethral radiofrequency cathter for Benign Prostatic Hyperplasia Joint Principal Investigator.
January 2003 – January 2006: American Medical Systems Australasian multi-centre prospective study to evaluate the safety and efficacy of American Medical Systems SPARC Sling System for the treatment of urinary stress incontinence. Joint Principal Investigator
October 2005 – ongoing: Uromedica, FDA Study, Adjustable Continence Therapy (ProACT) Periuretheral Prostatic System for treatment of Stress Urinary Incontinence in post prostatectomy patients. Investigator.

Pharmaceutical Multicentre Studies (Site Principal Investigator):

July 1999 – November 2000: GlaxoWelcome, ARI40001 – Efficacy of GI198745 versus Finasteride for BPH.
June 2001 – November 2002: Yamanouchi, YM905-CL-015 – Comparison of Placebo, YM905 and Tolterodine for Overactive Bladder Syndrome.
June 2001 – November 2002: Yamanouchi, YM905-CL-018 – Comparison of Placebo and YM905 for Overactive Bladder Syndrome.
November 2001 – November 2002: Yamanouchi, YM905-CL-019 – Long term Safety and Efficacy Follow-up of YM905 for Overactive Bladder Syndrome.
August 2001 – May 2002: Abbott, WO1-366 – Safety and Efficacy of Uprima for Male Erectile Dysfunction.
September 2002 – April 2003: GlaxoSmithKline, SB782528 001 – Efficacy and Safety of Vardenafil vs Placebo for Male Erectile Dysfunction Unresponsive to Sildenafil Therapy.
September 2002 – June 2003: Yamanouchi, 02-OMN-02 – Efficacy and Safety of Tamsulosin vs Placebo.
May 2002 – July 2006: Abbott, MOO-211 – Safety and Efficacy of Atrasentan in Men with Metastatic, Hormone-Refractory Prostate Cancer Study.
May 2002 – July 2006: Abbott, MOO-244 – Safety and Efficacy of Atrasentan in Men with Non-Metastatic, Hormone-Refractory Prostate Cancer Study.
May 2002 – May 2007: Abbott, MOO-258 – Safety of Atrasentan in Men with Hormone-Refractory Prostate Cancer.
January 2003 – ongoing: GlaxoSmithKline, ARI40006, Efficacy and Safety of Dutasteride vs Placebo to Reduce the Risk of Biopsy-detected Prostate Cancer.
May 2003 – November 2004: Merck Sharp and Dohme, MK-966, Effect of Rofecoxib in Decreasing the Risk of Prostate Cancer.
July 2003 – ongoing: Schwarz Biosciences, SP583, Efficacy, Tolerability and Safety of Fesoterodine for Over Active Bladders.
March 2005 – May 2006: Sanofi, The study of SR31747A compared to placebo in men with non-metastatic prostate cancer.
February 2006 - ongoing: Novartis, Phase III, parallel group, randomised, open label, multi centre clinical trial of Zometa in males receveing Androgen Deprivation Thereapy for advanced prostate cancer.
February 2006 – April 2007: Merck Sharp & Dohme, The study of L-796568 in post menopausal women with OveractiveBladder
March 2006 – ongoing: USANZ, Optimal Timing of Cryopreservation in Men with Testicular Cancer
July 2006 – March 2007: GSK, B3P104833 Oral Solabegron for the overactive bladder
August 2006 - ongoing: Amgen, A Randomised, Double-Blind, Placebo-Controlled, Multi-centre Phase 3 Study of Denosumab on Prolonging Bone Metastasis-Free Survival in Men with Hormone-Refractory Prostate Cancer
October 2006 – February 2008: Salvat, A Multi-Centre, Placebo Controlled, Randomised, Double-Blind, Dose Ranging Study of SVT-40776 0.05MG, 0.1MG, 0.2MG, Tolterodine 4MG and Placebo Daily Doses for 4 Weeks in Patients Suffering from Overactive Bladder Syndrome
October 2006 – September 2007: Merck Sharp & Dohme, A Multi-Centre, Double-Blind, Randomised, Placebo- and Active-Controlled, Parallel-Group, Dose-Ranging Study of MK-0594 in Patients with Overactive Bladder
March 2007 – ongoing: Amgen, A Randomised, Double-Blind, Multicenter Study of Denosumab Compared with Zoledronic Acid in the Treatment of Bone Metastases in Men with Hormone-Refractory Prostate Cancer
April 2008 – ongoing: Pacific Edge Biotechnology, A prospective study of a novel urine diagnostic test for the detection of urinary tract transitional cell carcinoma (TCC).

Publications:

Book Chapters

Gilling PJ, Macbeth WAAG. Postoperative Care and Complications. Chapter 18, Clinical Science for Surgeons, Ed Marshall VC and Ludbrook J. 2^nd Edition, Butterworths (1988).
Arnold EP, Gilling PJ. Abdominal Approaches to Surgery for Female Incontinence. Chapter 38, Glenn’s Urologic Surgery, Fifth Edition. Lippincott-Raven Publishers 1998.
Gilling PJ, Fraundorfer MR. Holmium Laser Prostatectomy. Chapter 9. 93-102:(2000). Benign Prostatic Hyperplasia: Laser and Heat Therapies. Martin Dunitz Publishers, London.
Aho T, Gilling PJ. Holmium Laser Prostatectomy. Holmium Laser: Endourology Applications. BI Publications (2003).
Neill M, Gilling PJ. Benign Prostatic Hyperplasia. Pp 18-30. Fast Facts: Urology Highlights 2004-5
Fong E, Gilling PJ . Benign Prostatic Hyperplasia. Pp Fast Facts: Urology Highlights 2005-6
Tan AH, Gilling PJ. Holmium Laser Prostatectomy. Smiths Textbook of Endourology 2006 Pp 639-643 2^nd Edition.
Leyland J, Gilling PJ. Holmium Laser Prostatectomy versus Transurethral Resection of Prostate (Chapter 8) Interventional management of Urological Diseases 2006 (In Press)

Published Articles

Gilling PJ, MacFarlane MR, Rhode JC. Spinal Cord Compression from Metastasizing Cicatricial Carcinoma: A Case Report. J Neurosurg 21:553-557.
Gilling PJ, Wright WL, Gray JM. Intracorporeal Injection Therapy for Impotence: Preliminary Results. NZ Med J 1988;101:848, 423-424.
Gilling PJ, Wright WL Gray J. Factors Associated with Sexual Dysfunction Following Transurethral Resection of the Prostate. NZ Med J 1988;101:850, 484-485. (J Urol 1989; 142:461 (Abstract)Yearbook of Urology 1989 (Abstract)).
Gilling PJ. Recurrent Urinary Tract Infections in the Adult Female Patient. NZ Practice Nurse March 1994;4-6.
Gilling PJ, Cass CB, Malcolm AR, Fraundorfer MR. Combination Holmium and Nd: YAG Laser Ablation of the Prostate: Initial Clinical Experience. J Endourol 1995;9:2, 151-153.
Gilling PJ, Cass CB, Malcolm AR, Fraundorfer MR. Ablation of the Prostate using a Combination of Holmium and Nd:YAG Lasers. El Hospital September 1995;51:4
Gilling PJ, Cass CB, Cresswell M, Fraundorfer MR. Holmium Laser Resection of the Prostate: Preliminary Report of a New Technique for Benign Prostatic Hyperplasia. Urology 1996;47(1), 48-51.
GillingPJ, Cass CB, Cresswell MD, Malcolm AR, Fraundorfer MR. The Use of the Holmium Laser in the Treatment of Benign Prostatic Hyperplasia. J Endourol 1996;10(5), 459-461.
Gilling PJ, Cass CB, Cresswell MD, Kennett KM, Mackey M, Fraundorfer MR, Kabalin JN. The Evolution of the Use of the Holmium Laser for the Treatment of Benign Prostatic Hyperplasia. SPIE Proceedings 1997;2970:448-451.
Gilling PJ, Mackey M, Cresswell MD, Kennett K RN, Cass CB RN, Fraundorfer MR, Kabalin JN. The Perioperative Care of Patients Undergoing Holmium Laser Resection of the Prostate (HoLRP) Compared with Transurethral Resection of the Prostate (TURP). SPIE Proceedings 1998;3245:75-80.
Gilling PJ, Fraundorfer MR. Holmium Laser Prostatectomy: A Technique in Evolution. Current Opinion in Urology 1998;8:11-15.
Gilling PJ, Cass CB, Malcolm A, Cresswell M, Fraundorfer MR, Kabalin JN. Holmium Laser Resection of the Prostate (HoLRP) versus Neodymium: YAG Visual Laser Ablation of the Prostate (VLAP): A Randomised Prospective Comparison of Two Techniques for Laser Prostatectomy. Urol 1998;51:537-577.
Gilling P J, Kennett KM RN, Das A, Thompson D,Fraundorfer MR. Holmium Laser Enucleation of the Prostate (HoLEP) Combined with Transurethral Tissue Morcellation: An Update on the Early Clinical Experience. J Endourol, 12;5 October 1998;457-459.
Gilling PJ, Mackey M, Cresswell M, Kennett K, Kabalin JK, Fraundorfer MR. Holmium Laser Versus Transurethral Resection of the Prostate: A Randomized Prospective Trial with 1‑Year Follow‑up. J Urol 1999;162:1640‑1644.
Gilling PJ, Kennett KM, Fraundorfer MR. Holmium Laser Resection of the Prostate (HoLRP) versus Transurethral Resection of the Prostate (TURP): Results of a Randomised Trial with 2 years Follow‑up. J Endourol 2000;14:757-760.
Gilling PJ, Kennett KM, Fraundorfer MR. Holmium Laser Enucleation of the Prostate (HoLEP) for Prostates Larger than 100g: An Endourologic Alternative to Open Prostatectomy. J Endourol 2000;14:529-531.
Gilling PJ. Large BPH should be treated by Open Prostatectomy: Against the motion. European Urology 2007; Mar 51(3): 845
Gilling PJ, Aho T, King C, Frampton C, Fraundorfer M. Holmium Laser Enucleation of the Prostate: Results at 6 years. Eur Urol 2007 (Online version)
Gilling PJ. Prostate Cancer following BPH Treatmenrs: What the patient should know. Eur Urol 2007 (Epub ahead of print)
Gilling PJ. Laser Vaporization of the Prostate: Are we there yet? Eur Urol 2007 (Epub ahead of print).
Muschter R, Gilling PJ. Laser for Median Lobe Hyperplasia. Current Urology Reports 2001;2:306-310.
Tan A, Gilling PJ. Free Beam and Contact Laser Soft Tissue Ablation in Urology JEndourol October 2003;17.
Cresswell MD, Cass CB, Fraundorfer MR, Gilling PJ. Holmium: YAG Laser Resection of the Prostate: Preliminary Experience with the First 400 Cases. NZ Med J 1997;110:76‑8.
Kabalin JN, Mackey MJ, Cresswell MD, Fraundorfer MR, Gilling PJ. Holmium: YAG Laser Resection of Prostate (HoLRP) for Patients in Urinary Retention. J Endourol 1997;11, 4:293-295.
Le Duc A, Gilling PJ. Holmium Laser Resection of the Prostate. Eur Urol 1999;35:155-160.
Fraundorfer MR, Gilling PJ. Holmium: YAG Laser Enucleation of the Prostate Combined with Mechanical Morcellation: Preliminary Results. Eur Urol 1998;33:69-72.
Fraundorfer MR, Dunton NG, Kennett KM, Gilling PJ. Holmium Laser Resection of the Prostate is More Cost Effective than Transurethral Resection of the Prostate: Results of a Randomised Prospective Study. Urology 57, 3:454-458.
Das A, Gilling PJ, Fraundorfer MR. Holmium Laser Resection of Bladder Tumours (HoLRBT). Tech. Urol 1998;4, No 1, 12-14.
Das A, Kennett KM, Sutton T, Fraundorfer MR, Gilling PJ. Histologic Analysis of Tissue Obtained from Holmium: YAG Laser Resection of the Prostate (HoLRP) Compared to Transurethral Resection of the Prostate (TURP). J Endourol 2000;14:459-462.
Masters JE, Fraundorfer MR, GillingPJ. Extraperitoneal Laparoscopic Pelvic Lymph Node Dissection Using the Gaur Balloon Technique. BJU 1994;74:128-129.
Boone TB, Gilling PJ, Husmann DA. Ureteropelvic Junction Disruption Following Blunt Abdominal Trauma. J Urol 1993;150:33-36.
Husmann DA, Gilling PJ, Perry MO, Morris JS, Boone TB. Major Renal Lacerations with a Devitalized Fragment Following Blunt Abdominal Trauma: A Comparison Between Non-Operative (Expectant) versus Surgical Management. J Urol 1993;150:1774-1777.
Cable RL, Gilling PJ, Jones WO. Laparoscopic Extraperitoneal Inguinal Hernia Repair Using a Balloon Dissection Technique. ANZ J Surg 1994;64:431-433.
Jones WO, Cable RL, Gilling PJ. Laparoscopic Pelvic Lymphadenectomy for Malignant Melanoma. ANZ J Surg 1995;65:765-767.
Bergman J, Gilling PJ, Greenslade WP. Tuberculosis Epididymitis: A Case Report. NZ Med J 1989;102:878, 552.
Kabalin JN, Gilling PJ, Fraundorfer MR. Holmium: YAG Laser Prostatectomy. Mayo Clinic Proceedings, August 1998;73(8):792-797.
Kabalin JN, Gilling PJ, Fraundorfer MR. Application of the Holmium: YAG Laser Prostatectomy. Journal of Clinical Laser Medicine and Surgery 1998;16, 1:21-27.
Das A, Kennett K, Fraundorfer M, Gilling P. Holmium Laser Resection of the Prostate (HoLRP): 2 Year Follow-up Date. Tech Urol 2001 Dec;7(4):252-5.
Tan AHH, Gilling PJ. Holmium Laser Prostatectomy: Current Techniques. Urol 2002; 60:152-156.
Muschter R, Gilling P. Lasers for Median Lobe Hyperplasia. Curr Urol Rep August 2001;2(4):306-10.
Tan A, Gilling P. Holmium Laser Prostatectomy – A Review. BJUI 2003;92:527-530.
Tan A, Gilling G, Kennett K, Fletcher H, Fraundorfer M. Long Term Results of Holmium Laser Ablation of the Prostate. BJUI 2003;92:707-709.
Aho F, Gilling PJ. Laser Therapy for Benign Prostatic Hyperplasia: A Review of Recent Developments. Current Opinion in Urology, January 2003;13.1.
Tan A, Gilling P. Free-Beam and Contact Laser Soft-Tissue Ablation in Urology. JEndourol October 2003;17, 8:587.
Tan AHH, Gilling PJ, Kennett KM, et al. Randomized Trial Comparing Holmium Laser Enucleation of Prostate with Transurethral Resection of Prostate for Treatment of Bladder Outlet Obstruction Secondary to Benign Prostatic Hyperplasia in Large Glands (40 to 200 grams). J Urol 2003;170:1270.
McAlister WJ, Gilling PJ. Vaporization of the Prostate. Curr Op Urol 2004;14:31-34.
Tooher R, Sutherland P, Costello A, Gilling P, Rees G, Maddern G. A Systematic Review of Holmium Laser Prostatectomy for Benign Prostatic Hyperplasia. J Urol 2004;171:1773-1781.
Westenberg A, Gilling P, Kennett K, Frampton C, Fraundorfer M. Holmium Laser Resection of the Prostate(HoLRP) versus Transurethral Resection of the Prostate (TURP): Results of a Randomised Trial with Long- term Follow-up (4 Year Minimum). J Urol August 2004;172, 616-619.
Wilson L, Kennett K, Gilling P. Laparoscopic Radical Prostatectomy: An Analysis of the Learning Curve. ANZ J Surg 2004 ; 74:1065-1068
Tan AH, Gilling PJ. Lasers in the treatment of benign prostatic hyperplasia: an Update Curr Opin Urol 2005 15:55-58
Aho T, Gilling P, Kennett K,Westenburg AM, Fraundorfer MR, Frampton CM. Holmium Laser Bladder Neck Incision versus Holmium Laser Enucleation of the Prostateas outpatient procedures for prostates less than 40 grams: A Randomized Trial. J Urol 2005; 174: 210-214
Kim SC, Matlaga BR, Kuo RL, Watkins SL, Kennett KM, Gilling PJ, Lingeman JE. Holmium Laser Enucleation of the Prostate: A Comparison of Efficiency Measures at Two Institutions. J Endourol 2005 19: 555-557.
Wilson LC, Gilling PJ. From Coagulation to Enucleation: the use of Lasers in sugery for Benign Prostatic Hyperplasia. Nature Clinical Practice: Urology (2005) 2: 443-8
Neill MG, Gilling PJ, Kennett KM, Frampton CM, Westenburg AM, Fraundorfer MR, Wilson LC. A Randomized Trial Comparing Holmium Laser Enucleation Of The Prostate(HoLEP) With Plasmakinetic Enucleation Of The Prostate(PkEP) For The Treatment Of Benign Prostatic Hyperplasia (BPH).Urology (2006) Nov;68(5):1020-4.
Wilson LC, Gilling PJ, Williams A, Kennett KM, Frampton CM, Westenberg AM, Fraundorfer MR. A Randomised Trial Comparing Holmium Laser Enucleation Versus Transurethral Resection in the Treatment of Prostates Larger Than 40Grams: Results at 2 Years .Eur Urol. 2006 Sep;50(3):569-73.
Wilson LC, Gilling PJ. Lasers for Prostate Surgery – An Update. Benign Prostate Hyperplasia. Business Briefing: European Kidney & Urological Disease (2006);52-53.
Gilling PJ. Holmium Laser Enucleation of the Prostate(HoLEP). Surgery Illustrated. BJUI Int. 2008 Jan;101(1):131-42.
Gilling PJ. Prostate Cancer Following BPH Treatments: What The Patient Should Know. Eur Urol. 2007 Aug [Epub ahead of print].
Gilling PJ. Laser Vaporization Of The Prostate: Are We There Yet? Eur Urol. 2007 Dec;52(6):1569-70.
Gilling PJ, Aho TF, Frampton CM, King CJ, Fraundorfer MR. Holmium Laser Enucleation Of The Prostate: Results at 6 Years. Eur Urol. 2008 Apr;53(4):744-9.
Rigatti P, Cestari A, Gilling P. The Motion: Large BPH Should Be Treated By Open Surgery. Eur Urol. 2007 Mar;51(3):845-7; discussion 847-8.
Gilling PJ, Williams AK. HoLEP Is The Single Best Treatment For BPH Refractory To Medication. J Endourol 2007 Debate: (In Press)
Gilling PJ, Bell D, Wilson LC, Westenberg AM, Reuther R, Fraundorfer MR. The Adjustable Continence Therapy (ProACT^TM) Device For The Treatment Of Post-Prostatectomy Incontinence: A Minimum of 2 Years Follow-Up. BJUI 2008. (In Press)
Gilling PJ, Aho TF. Current Techniques For Laser Prostatectomy-PVP and HoLEP. Arch.Esp.Urol. 2008 (In Press).
Wilson LC, Gilling PJ. Holmium Laser For Treatment Of BPH. Current Bladder Dysfunction Reports 2008 3:3 (In Press).

Published Abstracts

· Gilling PJ, Graham S, Yeo KHJ, Whelan PB, Arnold EP. Human Detrusor Muscle Collagen Content: A New Computer Assisted Method of Analysis. Proceedings Christchurch Medical Research Society, NZ Med J 1989;102:879,592.
· Gilling PJ, vanMastrigt R, Arnold EP. Contractility of Bladder Muscle in Patients Undergoing Prostatectomy. NZ Med J 1990;103: 888, 188.
· Gilling PJ, van Mastrigt R, Arnold EP. The Contractility of Detrusor Muscle from Patients Undergoing Elective Transurethral Resection of the Prostate. BJU 1991;67:400.
· Arnold EP, MarkSD, Gilling PJ. Bladder Muscle Contractility and the Non-Contractility Elements. Neurourol. Urodyn 1991;10:(4), 407-408.
· Arnold EP, Gilling PJ. Bladder Contractility Assessments: A Brief Review. BJU 1991;67:394-395.
· Mark SD, Gilling PJ, Frampton C, van Mastrigt R, Arnold EP. Detrusor Contractility: Its Measurement and the Effect of Age and Sex in Normal Control Patients. NZ Med J 1990.
· Boone TB, Gilling PJ, Husmann DA .Ureteropelvic Junction Disruptions Following Blunt Abdominal Trauma in the Paediatric Patient. J Urol 1992;142(4)276A.
· Gilling PJ, Perry MO, Boone TB, Husmann DA. Management of Devitalized Renal Fragments Following Blunt Abdominal Trauma: A Comparison of Non-Operative (Expectant) Versus Surgical Management. J Urol 1993;149(4) 486a:1093.
· Gilling PJ, Fraundorfer MR, Sealey C, WattsHG. Laparoscopic Extraperitoneal Approaches to Female Urinary Incontinence: The Colposuspension and Pubovaginal Sling. J Urol 1994;151(5) 344A:467.
· Gilling PJ, Fraundorfer MR. Laparoscopic Extraperitoneal Bladder Neck Suspension. J Endourol 1994;8 (Supp 1):V5-120.
· Gilling PJ, Cass CB, Fraundorfer MR. Combination Endoscopic Laser Ablation of the Prostate (CELAP): The Next Generation Laser Prostatectomy? J Endourol 1994 (Supp 8):16-356.
· David RD, Fuchs GJ, Patel A, Gilling PJ, Fraundorfer MR. Holmium Laser Resection of the Prostate: A New Alternative to Electrosurgical Resection of the Prostate. J Endourol 1995;(Vol 9 Suppl):V12-418.
· Gilling PJ, Cass CB, Fraundorfer MR. The Use of the Holmium Laser in the Treatment of Benign Prostatic Hyperplasia. J Endourol 1995;(Vol 9 Suppl):O4-66.
· Fraundorfer MR, Cass CB, Gilling PJ. Holmium Laser Resection of the Prostate: Experience with the First One Hundred Cases. J Endourol 1995;(Suppl 9):
5-178.
· Malcolm A, Gilling PJ. Prostate Volume Estimation: A Comparison of Techniques. Aust NZ J Surg, 1996;66(6):377.
· Gilling PJ, Malcolm AR, Fraundorfer MR. Laparoscopic Extraperitoneal Bladder Neck Suspension with Urodynamic Follow-up Beyond 6 Months. ANZ J Surg 1996;66(6):389.
· Gilling PJ, Fraundorfer MR, Kabalin JN. Holmium Laser Resection of the Prostate versus Nd: YAG Coagulation Prostatectomy: A Randomised Prospective Urodynamics-based Trial. J Urol 1996;155(5):318A(30).
· Fraundorfer MR, Gilling PJ, Kabalin JN. The Holmium Laser in the Treatment of Benign Prostatic Hyperplasia. J Urol 1996;155(5):318A(29).
· Fraundorfer MR, Cass CB, Gilling PJ. Combination Holmium and Nd: YAG Laser Ablation of the Prostate: Early Clinical Experience. ANZ J Surg 1996;66(6):384.
· David RD, Fuchs GJ, Patel A, Gilling PJ, Fraundorfer MR. Holmium Laser Resection of the Prostate: A New Alternative to Electrosurgical Resection of the Prostate. Urol 1996; 155(5):576A(1062).
· Gilling PJ, Cass CB, Fraundorfer MR, Kabalin JN. Holmium Laser Resection of the Prostate (HoLRP) versus Nd: YAG Coagulation Prostatectomy (VLAP): A Randomised, Prospective, Urodynamics-Based Trial. ANZ J Surg 1997;67:6;369.
· Fraundorfer MR, Cass CB, Gilling PJ, Kabalin JN. The Holmium Laser in the Treatment of Benign Prostatic Hyperplasia. ANZ J Surg 1997;67:6;377.
· Fraundorfer MR, Cass CB, Gilling PJ, Kabalin JN. The Holmium Laser in the Treatment of Benign Prostatic Hyperplasia. Euro Urol 1996;30 (Supp 2):355.
· Gilling PJ, Cass CB, Fraundorfer MR, Kabalin JN. Holmium Laser Resection of the Prostate Versus Nd: YAG Coagulation Prostatectomy: A Randomised, Prospective, Urodynamics-Based Trial. Euro Urol 1996;30, (Supp 2):395.
· Kabalin JN, Mackey MJ, Cresswell MD, Fraundorfer MR, Gilling PJ. Holmium: YAG Laser Resection of the Prostate (HoLRP) for Patients in Urinary Retention. Endourol 1996;10 (Supp 1):03-269.
· Gilling PJ, Fraundorfer MR, Kabalin JN. Holmium: YAG Laser Resection of the Prostate (HoLRP) versus Transurethral Electro-cautery Resection of the Prostate (TURP): A Prospective Randomised Urodynamics-Based Clinical Trial. J Urol 1997;157:4:149.
· Chilton CP, Gilling PJ, Fraundorfer MR, Cresswell MD. The Results of Holmium Laser Resection of the Prostate. B J Urol 1997;79 (Supp 4):226, 61.
· Fraundorfer MR, Gilling PJ. Holmium Laser Enucleation of the Larger Prostate (HoLEP) Combined with Mechanical Morcellation. J Endourol 1997;l 11 (Supp 1):S159.
· Gilling PJ, Cresswell MD, Fraundorfer MR, Kabalin JN. Holmium Laser Resection of the Prostate (HoLRP) vs Transurethral Resection of the Prostate (TURP). J Endourol 1997; 11 (Supp 1):S161.
· Fraundorfer MR, Gilling PJ, Priscott P. Steralex^TM: An alternative to Glutaraldehyde. JEndourol 1997;11 (Supp 1):S189.
· Fraundorfer MR, Cresswell MD, Gilling PJ, Kabalin JN. Bladder Tumour Resection with the Holmium Laser. B J Urol 1997;80 (Supp 2):151, 39.
· Gilling PJ, Cresswell MD, Fraundorfer MR, Kabalin J. Holmium Laser Resection of the Prostate (HoLRP) vs Transurethral Resection of the Prostate (TURP). B J Urol 1997;80 (Supp 2):764, 196.
· Fraundorfer MR, Gilling PJ. Holmium Laser Enucleation of the Larger Prostate Combined with Mechanical Morcellation: An Alternative to Open Prostatectomy. B J Urol 1997;80 (Supp 2):823, 210.
· Gilling PJ, Kennett KM, Fraundorfer MR. Holmium Laser Enucleation of the Prostate (HoLEP) Combined with Intracavitary Morcellation: Early Results. J Urol 1998;159 5:1168.
· Gilling PJ, Kennett KM, Fraundorfer MR. Holmium Laser Resection of the Prostate (HoLRP) versus Transurethral Resection of the Prostate (TURP): Follow-up at 1 year. JUrol 1998;159 5:955.
· Gilling PJ, Kennett KM, Mackey M, Fraundorfer MR. Holmium Laser Resection of the Prostate (HoLRP) versus Transurethral Resection of the Prostate (TURP): Analysis at 1year. J Endourol 1998;12 (Supp 1):F2-3:S107.
· Das A, Fraundorfer MR, Gilling PJ. Holmium Laser Resection of the Prostate (HoLRP): Two Year Follow-up Data. J Endourol 1998;12 (Supp 1):F16-2:S195.
· Gilling PJ, Kennett KM, Fraundorfer MR. Holmium Laser Enucleation of the Prostate (HoLEP) Combined with Intravesical Tissue Morcellation. J Endourol 1998;12 (Supp 1): F16-7:S196.
· Gilling PJ, Kennett KM, Fraundorfer MR. Holmium Laser Resection of the Prostate (HoLRP) is More Cost-Effective than Transurethral Resection of the Prostate (TURP): Actual Values Based on a Randomised Prospective Trial. J Endourol 1998;12 (Supp 1): F16-8:S196.
· Das A, Sutton T, Fraundorfer MR, Gilling PJ. Histological Analysis of Tissue from Holmium Laser Resection of the Prostate (HoLRP). J Endourol 1998;12 (Supp 1): F16-11:S197.
· Gilling PJ, Kennett K, Fraundorfer M. Laser Enucleation of the Prostate (HoLEP) Combined with Intravesical Tissue Morcellation. Eur Urol 1999;35 (Supp 2) 104.
· Gilling PJ, Fraundorfer MR. Radical Perineal Prostatectomy (RPP) vs Radical Retropubic Prostatectomy (RRP): Less Morbidity and Similar Efficacy with Short-term Follow-up. ANZ J of Surg June 1999;69 6:8, A106.
· Gilling PJ, Kennett K, Fraundorfer MR. Holmium Laser Enucleation of the Prostate (HoLEP) Combined with Intracavitary Morcellation: Early Results. ANZ J of Surg June 1999;69 6:15, A108.
· Das A, Cresswell M, Fraundorfer M, Gilling P. Two Year Follow-up of Holmium Laser Resection of the Prostate. ANZ J of Surg June 1999;69 6:14, A108.
· Fraundorfer MR, Dunton N, Das A, Gilling PJ. Holmium Laser Resection of the Prostate is More Cost-Effective than Transurethral Resection of the Prostate: Actual Values Based on a Randomised Prospective Trial. ANZ J of Surg June 1999;69 6:42, A115.
· Das A, Gilling PJ, Fraundorfer MR, Sutton T. Histological Analysis of Tissue from Holmium Laser Resection of the Prostate (HoLRP). ANZ J of Surg June 1999;69 6:43, A115.
· Hawke CK, Fraundorfer MR, Gilling PJ. Irrigant Absorption During Holmium Laser Resection of the Prostate (HoLRP): Assessment by the use of Expired Breath Ethanol. JUrol 1999;A1167:303.
· Gilling PJ, Kennett K, Fraundorfer MR. Holmium Laser Enucleation of the Prostate (HoLEP) Combined with Intravesical Tissue Morcellation. Eur Urol 1999;A415:104.
· Gilling PJ, Kennett K, Fraundorfer MR. Holmium Laser Resection of the Prostate (HoLRP) versus Transurethral Resection of the Prostate (TURP): Analysis at 1 year Eur Urol 1999;A416:104.
· Gilling PJ, Kennett KM, Fraundorfer MR. Holmium Laser Enucleation of the Prostate (HoLEP) for Prostates Greater than 100ml in Volume. J Endourol 1999;FP2‑3:A28.
· Gilling PJ, Kennett KM, Fraundorfer MR. Holmium Laser Resection of the Prostate (HoLRP) vs Transurethral Resection of the Prostate (TURP): Results of a Randomised Trial with 2 year Follow-up. J Endourol 1999;PS14-1:A109.
· Gilling PJ, Kennett KM, Westenberg AM, Donaldson S, Fraundorfer MR. Holmium Laser Enucleation of the Prostate (HoLEP) vs TURP in the Larger Prostate: Results of a Randomised Trial. ANZ J of Surg February 2000;70 2:10, A3.
· Gilling PJ, Kennett KM, Fraundorfer MR. Holmium Laser Enucleation of the Prostate (HoLEP) versus Transurethral Resection of the Prostate (TURP) for Large Prostate Glands (40-200g): Early Results. J Endourol 2000;14, (Supp 1), P5-3:A35.
· Gilling PJ, Kennett KM, Bell D, Fraundorfer MR. Extracorporeal Magnetic Stimulation (ExMI) for the Treatment of Stress Urinary Incontinence in Women. J Endourol 2000;14, (Supp 1), P15-2:A76.
· Gilling PJ, Kennett KM, Fraundorfer MR. Holmium Laser Resection of the Prostate (HoLRP) vs Transurethral Resection of the Prostate (TURP): Results of a Randomized Trial with 2 Year Follow-up. J Urol 2000;163, 4, A1191, 268.
· Gilling PJ, Kennett KM, Fraundorfer MR. Holmium Laser Resection of the Prostate (HoLRP) versus Transurethral Resection of the Prostate (TURP): Results of a Randomized Trial with 2-Year Follow-up. ANZ J of Surg 2000;70, 9, 15, A160.
· Gilling PJ, Kennett KM, Fraundorfer MR. Holmium Laser Enucleation of the Prostate (HoLEP) for Prostates >100g. ANZ J of Surg 2000;70, 9, 16, A161.
· Gilling PJ, Kennett KM, Fraundorfer MR. Extracorporeal Pulsed Magnetic Stimulation for the Treatment of Stress Urinary Incontinence in Women. ANZ J of Surg 2000;70, 9, 17, A161.
· Gilling PJ, Kennett KM, Bell D, Fraundorfer MR. Extracorporeal Magnetic Stimulation (ExMI) for the Treatment of Stress Urinary Incontinence in Women. BJU 2000;86 (Supp 3), P2.4.08.
· Gilling PJ, Kennett KM, Fraundorfer MR. Holmium Laser Enucleation of the Prostate (HoLEP) for Prostates Greater than 100g. BJU 2000;86, (Supp 3), MP3.2.07.
· Gilling PJ, Dunton N, Kennett KM, Fraundorfer MR. Holmium Laser Resection of the Prostate (HoLRP) is more Cost-effective than Transurethral Resection of the Prostate (TURP): Actual Values Based on a Randomised Prospective Trial. BJU 2000;86 (Supp 3), P7.4.19.
· Gilling PJ, Kennett KM, Fraundorfer MR. Holmium Laser Resection of the Prostate (HoLRP) vs Transurethral Resection of the Prostate (TURP): Results of a Randomised Trial with 2 Year Follow-up. BJU 2000;86 (Supp 3), P7.4.20.
· Gilling PJ, Kennett KM, Bell D, Fraundorfer MR. Extracorporeal Magnetic Stimulation vs Sham Treatment for Female Genuine Stress Urinary Incontinence: A Randomised Trial. BJU 2001;88 (Supp 1), 56.20.
· Gilling PJ, Kennett KM, Fraundorfer MR. Holmium Laser Enucleation of the Prostate vs TURP for Large Prostates (40-200g). BJU; 88, P81.43.
· Gilling PJ, Kennett KM, Bell DM, Wrigley T, Fraundorfer MR. A Double Blind Randomised Trial Comparing Magnetic Stimulation of The Pelvic Floor to SHAM Treatment for Women with Stress Urinary Incontinence. Neur and Urodyn 2001;20, 38.432.
· Gilling PJ, Kennett KM, Bell D, Fraundorfer MR. Extracorporeal Magnetic Stimulation (EXMI) vs SHAM Treatment for Female Genuine Stress Urinary Incontinence. A Randomised Trial. J Urol 2001;165, 5, 818.197.
· Gilling PJ, Kennett KM, Fraundorfer MR. Holmium Laser Enucleation of the Prostate (HoLEP) vs Transurethral Resection of the Prostate (TURP) for Large Prostate Glands (40-200g). Eur Urol 2001;39 (Supp 5), 158.
· Gilling PJ, Kennett KM, Bell D, Fraundorfer MR. Extracorporeal Magnetic Stimulation (EXMI) vs SHAM Treatment for Female Genuine Stress Urinary Incontinence: A Randomised Trial. Eur Urol 2001;39 (Supp 5) 287.
· Gilling PJ, Kennett KM, Fraundorfer MR. Holmium Laser Enucleation of the Prostate (HoLEP) is Superior to TURP for the Relief of Bladder Outflow Obstruction (BOO).
J Endourol;15 (Suppl 1) A5-P6.
· Gilling PJ, Kennett KM, Bell D, Fraundorfer MR. Clinical Examination can Determine the Likely Success of Magnetic Stimulation of the Pelvic Floor (ExMI) and/or Pelvic Floor Muscle Training (PFMT) In Women with Stress Urinary Incontinence. J Endourol;15 (Suppl 1) B4-P3.
· Gilling PJ, Kennett KM, Westenberg A, Fraundorfer MR. Holmium Laser Resection of the Prostate (HoLRP) Vs Transurethral Resection of the Prostate (TURP): Both Procedures Produce Durable Results at 4 years. J Endourol;15 (Supp1) C5-P20.
· Pauer P, Woo H, Mazza O, Gilling PJ, Gutierrez J. Transurethral Ethanol Ablation of the Prostate (TEAP), Initial Report of a Prospective Multi-Centre Study. Eur Urol 2002;
(Supp 1: No 1) 511.
· Gilling PJ, Kennett KM, Westenberg A, Fraundorfer MR. The Bioflow™ Biodegradable Stent for the Treatment of Bulbar Urethral Strictures: Initial Clinical Experience. JEndourol 2002;16 (Suppl 1), September 2003, P17-6, A85.
· Gutierrez-Aceves J, Gilling PJ. Transurethral Ethanol Ablation of the Prostate (TEAP), Initial Long-term Report of Prospective Multi-centre Studies. JEndourol September 2002;16 (Suppl 1), P11-3, A47.
· Gilling PJ, Kennett KM, Westenberg A, Fraundorfer MR. Evaluation of the Periurethral Adjustable Continence Therapy (ACT™) Device for the Treatment of Post Prostatectomy Incontinence: Preliminary Results. J Endourol September 2002;16 (Supp1 1), P25-11, A141.
· Gilling PJ, Kennett KM, Westenberg A, Fraundorfer MR. Holmium Bladder Neck Incision (HoBNI) Vs Holmium Laser Enucleation of the Prostate (HoLEP) as Outpatient Clinic Procedures for Small Prostate Glands (<40gm): A Randomised Trial with One Year Follow-up. J Endourol September 2002;16 (Suppl 1), 23-11, A128.
· Gilling PJ, Westenberg A, Kennett K, Fraundorfer MR. Holmium Laser Resection of the Prostate (HoLRP) Vs Transurethral Resection of the Prostate (TURP): Results at 4 Years. Eur Urol 2002 (Suppl 1 No 1), 666.
· Gilling PJ, Kennett KM, MacDonald J, Lerner L. Laparoscopic Radical Retropubic Prostatectomy: Early Experience. ANZ J of Surg. June 2002; 72, 6, A132, 26.
· Gilling PJ. Holmium Laser Resection of the Prostate (HoLRP) Vs Transurethral Resection of the Prostate (TURP). J Urol 2002;176, 4, A1158, 293.
· Gilling PJ, Westenberg A, Kennett K, Fraundorfer MR. Holmium Laser Resection of the Prostate (HoLRP) vs TURP: Results at 4 Years. BJUI 2002;90 (Supp1), A060, 12.
· Gilling PJ, Kennett K, Westenberg A, Fraundorfer MR. Holmium Bladder Neck Incision (HoBNI) Vs Holmium Laser Enucleation of the Prostate (HoLEP) as Day-stay Procedures for Small Prostates (<40g): A Randomised Trial. BJ Urol 2002; 90 (Suppl 1), AP016, 26.
· Fraundorfer MR, Kennett KM, Gilling PJ. TVT Pubovaginal Sling: Preliminary Results. ANZ J of Surg Jul 2002;72, 7, A140.
· Lerner LB, Fong EDM, Gilling PJ. Continence and PSA after Radical Prostatectomy: Is there a Difference Between Retropubic and Perineal Approaches? ANZ J of Surg July 2002;72, 7, A142.
· Gilling PJ, Kennett KM, Fraundorfer MR. Holmium Laser Enucleation of the Prostate versus Transurethral Resection of the Prostate for Large Prostate Glands (40-200g). ANZ J of Surg. Jul 2002;72, 7, A144.
· Gilling PJ, Kennett KM, Westenberg A, Fraundorfer MR. Holmium Laser Enucleation of the Prostate (HoLEP) Combined with Transurethral Mechanical Morcellation is Superior to TURP for the Relief of Bladder Outflow Obstruction (BOO). J Endourol Aug 2002;16, 6, 397.
· Gilling PJ, Kennett K, Westenberg AM, Fraundorfer MR. Holmium Laser Enucleation of the Prostate (HoLEP) is Superior to TURP for the Relief of Bladder Outflow Obstruction (BOO): A Randomised Trial with Two Year Follow up. Eur Urol Feb 2003;2, 1:403.
· Gilling PJ, Kennett K, Westenberg AM, Fraundorfer MR. The Bioflow^tm Biodegradable Stent for the Treatment of Bulbar Urethral Strictures: Initial Clinical Experience. Eur Urol Feb 2003;2, 1:589.
· Huebner W, Rocha FT, Gilling PJ, et al. International Multi-Centre Study Assessing the Safety and Efficacy of the Adjustable Continence Therapy (PROACT^TM) for the Treatment of Post Radical Prostatectomy Incontinence: Preliminary Results. J Urol April 2003;169, 4:473.
· Plante M, Palmer J, Martinez-Sagarra J, Guttierez J, Gilling PJ. Complications Associated with Transurethral Ethanol Ablation of the Prostate for the Treatment of Benign Prostatic Hyperplasia: A Worldwide Experience. J Urol Apr 2003;169, 4:1466.
· Gilling PJ, Kennett KM, Westenberg AM, Fraundorfer MR. Holmium Laser Enucleation of the Prostate (HoLEP) is Superior to TURP for the Relief of Bladder Outflow Obstruction (BOO): A Randomised Trial with 2 Year Follow up. J Urol Apr 2003;169, 4:1467.
· Gutierrez-Aceves J, Gilling PJ, Schettine M. Transurethral Ethanol Ablation of the Prostate (TEAP), Initial Long Term Report of Two Prospective Multi-centre Studies. J Urol Apr 2003;169, 4:1747.
· Gilling P, Kennett KM, Westenberg A, Fraundorfer MR. Holmium Laser Enucleation of the Prostate Vs Plasmakinetic (Gyrus) Enucleation of the Prostate: Early Results. J Endo September 2003;17, (Suppl 1), MP02.01.
· Gilling PJ, Kennett KM, Westenberg AM, Fraundorfer MR. Holmium Laser Enucleation of the Prostate (HoLEP) is Superior to TURP for the Relief of Bladder Outflow Obstruction (BOO): A Randomised Trial with Two Year Follow Up. J Endo Sep 2003;17, 1. MP02.07.
· Gilling PJ, Kennett KM, Westenberg AM, Fraundorfer MR. Evaluation of the Periurethral Adjustable Continence Therapy (ACT™) Device for the Treatment of Post Prostatectomy Incontinence: Preliminary Results. J Endo Sep 2003;17, 1, MP02.21.
· Fraundorfer MR, Gilling PJ. Brachytherapy for Carcinoma of the Prostate: The First 110 Cases from a Single New Zealand Centre. ANZ J of Surg June 2003;73,6:22.
· Gilling P, Kennett K, Westenberg A, Fraundorfer M. Holmium Bladder Neck Incision (HoBNI) Vs Holmium Laser Enucleation of the Prostate (HoLEP) as Day-Stay Procedures for Small Prostate Glands (<40G): A Randomized Trial. ANZ J of Surg June 2003;73,6:28.
· Gilling PJ, Westenberg AM, Kennett K, Fraundorfer MR. Holmium Laser Resection of the Prostate (HoLRP) Vs Transurethral Resection of the Prostate (TURP): Results at 4 Years. ANZ J of Surg. Jul 2003;73, 7, 58.
· Gilling PJ, Kennett K, Westenberg AM, Fraundorfer MR. The Bioflow™ Biodegradable Stent for the Treatment of Bulbar Urethral Strictures: Initial Clinical Experience. ANZ J of Surg Sep 2003;73,9:12.
· Tan A, Gilling PJ, Kennett K, Cresswell M, Fraundorfer MR. Long-Term Results of High-Powered Holmium Laser for Vaporization (Ablation) of the Prostate: 7 Years Follow-up. ANZ J of Surg October 2003;73, 10, 35.
· Gilling PJ. International Multi-Centre Study Evaluating the Adjustable Continence Therapy (PROACT) For Male Post Prostatectomy Stress Urinary Incontinence. J Urol May 2004;171, 4, 132.
· Gilling P, Kennett K, Westenberg A, Fraundorfer M. Holmium Laser Enucleation of the Prostate VS Plasmakinetic (Gyrus) Enucleation of the Prostate: A Randomised Trial with One Year Follow-up. J Urol May 2004;171, 4, 402.
· Gilling PJ, Kennett K, Aho T, Westenberg AM, Fraundorfer MR. Holmium Bladder Neck Incision (HOBNI) VS. Holmium Laser Enucleation of the Prostate(HOLEP) as Outpatient Clinic Procedures for Small Prostate Glands )<40G): Plasmakinetic (Gyrus) Enucleation of the Prostate. J Urol May 2004;171, 4, 410.
· Gilling PJ, Bell D, Kennett K, Westenberg AM, Fraundorfer MR. Evaluation of the Periurethral Adjustable Continence Therapy (ACT) Device for the Treatment of Post Prostatectomy Incontinence. Results at 1 Year. BJU June 2004;93, 4, 58.
· Gilling PJ, Kennett K, Westenberg AM, Fraundorfer MR. Holmium Laser Enucleation of the Prostate vs Plasmakinetic (Gyrus) Enucleation of the Prostate: A Randomised Trial with One Year Follow-up. BJU June 2004;93, 4, 108.
· Gilling PJ, Kennett K, Robertson P, Heaton J, Emerson L, Robb S. Multicentre Prospective Study to Evaluate the Safety and Efficacy of a Transurethral Catheter for Radiofrequency Ablation of the Prostate for Benign Prostatic Hyperplasia. J Endourol Nov 2004;MP 12/3, A74.
· Kim,SC, Tinmouth WW, Kuo RL, Kennett K, Gilling PJ, Lingeman JE. Holmium Laser Enucleation of the Prostate: A Comparison of Efficiency Measures at Two Institutions. J Endourol Nov 2004;MP 24/22, A140.
· Gilling PJ, Benness C, Bell D, Maxwell C. Multicentre Prospective Study to Evaluate the Safety and Efficacy of the SPARC Sling Procedure for Female Stress Urinary Incontinence (SUI). J Endourol Nov 2004;MP 26/7, A146.
· Gilling PJ, Hubner W, Trigo Rocha F, Sadi M, Palma P, Bell D. International Multi-Centre Study Evaluating the Adjustable Continence Therapy (PROACT) for Male Post Prostatectomy Stress Urinary Incontinence. J Endourol Nov 2004;MP 26/12, A147.
· Fraundorfer MR, Gilling PJ, Westenberg AM, Cresswell M. Holmium Laser BNI/Median Lobe Enucleation at Time of Volume Study Enables Patients Usually Excluded on Basis of Severe Outflow Obstruction to Undergo Prostate Brachytherapy: Initial Report. BJU February 2005;2 (Vol 95 Suppl 1).
· Gilling PJ, Fraundorfer MR, Westenberg AM, Kennett KM, Bell DF. Evaluation of the Periurethral Adjustable Continence Therapy (ACT) Device for the Treatment of Post Prostatectomy Incontinence: Results at 2 Years. BJU February 2005;5 (Vol 95 Suppl 1).
· Gilling PJ, Fraundorfer MR, Heaton JPW, Emerson L, Robb S, Kennett KM. A Pilot Study to Evaluate the Safety and Efficacy of a New Transurethral Catheter Radiofrequency Ablation Device (TruCATH^TM) for the Treatment of Benign Prostatic Hyperplasia. BJU February 2005;11 (Vol 95 Suppl 1).
· Gilling PJ, Jacobi G, Tammela TL, Van Erps P. Efficacy of Dutasteride and Finasteride for the Treatment of Benign Prostate Hyperplasia: Results of the 1-year Enlarged Prostate International Comparator Study (EPICS). BJU February 2005;12 (Vol 95 Suppl 1).
· Gilling PJ, Fraundorfer MR, Westenberg AM, Neill MG, Frampton CM, Kennett KM. Relief of Bladder Outflow Obstruction (BOO) Following HoLEP and TURP: A Pooled Analysis of Data from 4 Randomised Trials. BJU February 2005;14 (Vol 95 Suppl 1).
· Gilling PJ, Benness C, Maxwell C. Australasian Multi-centre Study to Evaluate the Safety and Efficacy of the SPARC Sling Procedure for Female Stress Urinary Incontinence: Results at One Year. BJU February 2005;25. U116 (Vol 95 Suppl 1).
· Fraundorfer MR, Bell D, Kennett K, Gilling PJ. The Use of a New and Innovative Device for the Management of Post-Brachytherapy Voiding Symptoms – A Pilot Study. BJU February 2005;26 (Vol 95 Suppl 1).
· Trigo-Rocha FE, Huebner W, Schlarp AM, Gilling PJ, Kocjancic E, Palma P, Sadi M, Carone R International Multi-Centre study evaluating the adjustable continence therapy (PROACT^TM) for male post prostatectomy stress urinary incontinence-mid-term results. J Urol 2005 May 173(4);545;149
· Gilling PJ, Neill MG, Kennett KM, Westenberg AM, Frampton CM, Fraundorfer MR. Relief of bladder outflow obstruction (BOO) following HoLEP and TURP: A pooled analysis of data from 4 randomised trials. J Urol 2005 May 173(4);1388;377
· Gilling PJ, Fraundorfer MR, Kennett K. Use of an innovative prostatic stent - the Spanner^TM for the treatment of dysuria and obstruction following minimally invasive procedures of the prostate. J Endourol. 2005 Aug 19(1):MP066-22
· Gilling PJ, Hubner W, Rocha-Trigo F, Sadi M, Palma P. Medium-term durability of the adjustable continence therapy (PROACT™) device for the treatment of post-prostatectomy stress urinary incontinence. J Endourol. 2005 Aug 19(1):MP07-14
· Gilling PJ, Kennett KM, Westenberg AM, Frampton CM, Fraundorfer. MR Relief of symptoms and obstruction following HoLEP and TURP – size matters: A metanalysis J Endourol. 2005 Aug 19(1):MP24-13
· Gilling PJ, Kennett KM, Westenberg AM, Fraundorfer MR, Wilson LM. The adjustable continence therapy (PROACT™) for the treatment of post-prostatectomy stress urinary incontinence: a comparison of two techniques. BJU March 2006; 88 (Vol 97, Suppl 1)
· Gilling PJ, Kennett KM, Westenberg AM, Wilson LC, Fraundorfer MR. Postoperative prostate specific antigen (PSA) decline predicts adequacy of adenoma removal with BPH surgical techniques. BJU March 2006; 95 (Vol 97, Suppl 1)
· Gilling PJ, Fong E, Westenberg AM, Wilson L, Fraundorfer AM. Postoperative prostate specific antigen (PSA) decline can predict the adequacy of the adenoma removal with BPH surgical techniques. Journal of Endoural. 2006 Aug 20(1):BR4-06
· Gilling PJ, Westenberg AM, Wilson LC, Fraundorfer MR. Plasmakinetic Superpulse™ TUR compared to Plasmakinetic™ enucleation of the prostate. Journal of Endoural. 2006 Aug 20(1):BR4-08
· Gilling PJ, Wilson LC, Westenberg AM, Fraundorfer MR, Bell D. A comparison of two techniques for the implantation of the adjustable continence therapy (PROACT™) for the treatment of post-prostatectomy stress urinary incontinence. Journal of Endoural. 2006 Aug 20(1):MP22-07
· Gilling PJ, Wilson LC, Meiklejohn P, Westenberg AM, Fraundorfer MR. The spectrum of use of the high-powered holmium laser in a laser training centre. Journal of Endoural. 2006 Aug 20(1):MP28-03
· Gilling PJ, Wilson LC, Bell D, Kennett K, Wrighley T, Fraundorfer MR. Pad testing and perineometry do not correlate with quality of life scores in women with stress incontinence. Journal of Endoural. 2006 Aug 20(1):VP10-07
· Gilling PJ, Fraundorfer MR, Donnell S, Tills M, Wilson LC, Westenberg AM. Medium-term results for l¹²⁵permanent seed brachytherapy in early stage prostate cancer. BJU Feb 2007; P12 (Vol 99, Suppl s2)
· Gilling PJ, King C, Williams A, Wilson LC, Westenberg AM, Fraundorfer MR. The long-term durability of holmium laser enucleation of the prostate (HoLEP). BJU Feb 2007; P34 (Vol 99, Suppl s2)
· Gilling PJ, Bell D, Wilson LC, Westenberg AM, Fraundorfer MR. The ProACT device for stress incontinence following surgery for BPH: technique and results. BJU Feb 2007; P38(Vol 99, Suppl s2)
· Williams A, Gilling PJ, Wilson LC, Meiklejohn P, Westenberg AM, Fraundorfer MR. Plasmakinetic Superpulse® TUR compared to Plasmakinetic® enucleation of the prostate. BJU Feb 2007; P41 (Vol 99, Suppl s2)
· Williams A, Gilling PJ, Wilson LC, Meiklejohn P, Westenberg AM, Fraundorfer MR. The spectrum of use of the high-powered holmium laser in a laser training centre. BJU Feb 2007; P45 (Vol 99, Suppl s2)
· Fraundorfer MR, Gilling PJ, Meiklejohn P, Wilson LC, Westenberg AM. Initial experience with renal and prostate cryotherapy. BJU Feb 2007; P64 (Vol 99, Suppl s2)
· Gilling PJ, King C, Williams A, Wilson LC, Westenberg AM, Fraundorfer MR. The Long-Term Durability of Holmium Laser Enucleation of the Prostate (HOLEP). European Urology March 2007; P682 (Vol 6, Issue 2)
· Gilling PJ, King C, Williams A, Wilson LC, Westenberg AM, Fraundorfer MR. The Long-Term Durability of Holmium Laser Enucleation of the Prostate (HOLEP). J Urol 2007 177; 577(1736).
· Gilling PJ, Heubner W, Kocjanic E, Trigo Rocha F. International Multicentre Evaluation Of The Adjustable Continence Therapy (ProAct^TM) For Male Post Prostatectomy Stress Urinary Incontinence. Eur Urol Suppl 2008;7(3):89.
· Huebner W, Kochancic E, Trigo Rocha F, Gilling PJ. International Long Term Evaluation Of The Adjustable Continence Therapy (ProAct^TM) For Male Post Prostatectomy Stress Urinary Incontinence.
J Urol 2008 179;511(1499).
· Gilling PJ, Wilson LC, Westenberg AM, Fraundorfer MR. A Randomized Trial Comparing The Long Term Results Of HoLEPAnd TURP In Urodynamically Obstructed Patients: Results At 7 Years. J Urol 2008 179;671(1954).
· Gilling PJ, Reuther R, Bell D, Wilson LC, Westenberg AM, Fraundorfer MR. The ProACT Device Does Not Impair The Urinary Flow Rate. J Urol (2007) 21(Suppl 1):MP07-15
· Gilling PJ, King C, Wilson LC, Westenberg AM, Fraundorfer MR. The Long-Term Results of TURP In Urodynamically Obstructed Patients. J Urol (2007) 21(Suppl 1):MP14-17
· Gilling PJ, Fong E, Wilson LC, Westenberg AM, Fraundorfer MR. Transition Zone Volume And Specimen Weight Following HoLEP. J Urol (2007) 21(Suppl 1):MP14-21

Peter Gilling FRACS

Promed Urology

Robotic Surgery

Research